Literature DB >> 21579442

5-Ethyl-4-methyl-1H-pyrazol-3(2H)-one.

Tara Shahani, Hoong-Kun Fun, R Venkat Ragavan, V Vijayakumar, S Sarveswari.   

Abstract

In the title compound, C(6)H(10)N(2)O, the 2,3-dihydro-1H-pyrazole ring is approximately planar, with a maximum deviation of 0.013 (1) Å. Pairs of inter-molecular N-H⋯O hydrogen bonds link neighboring mol-ecules into dimers, generating R(2) (2)(8) ring motifs. These dimers are further linked into two-dimensional arrays parallel to the bc plane by inter-molecular N-H⋯O hydrogen bonds. The crystal structure is further stabilized by C-H⋯π inter-actions.

Entities:  

Year:  2010        PMID: 21579442      PMCID: PMC2979558          DOI: 10.1107/S160053681001696X

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the background to and the biological activity of 3-ethyl-4-methyl-1H-pyrazol-5-ol, see: Brogden (1986 ▶); Coersmeier et al. (1986); Gursoy et al. (2000 ▶); Ragavan et al. (2009 ▶, 2010 ▶); Watanabe et al. (1984 ▶); Kawai et al. (1997 ▶); Wu et al. (2002 ▶). For related structures, see: Shahani et al. (2009 ▶, 2010 ▶). For hydrogen-bond motifs, see: Bernstein et al. (1995 ▶). For reference bond-length data, see: Allen et al. (1987 ▶). For the stability of the temperature controller used for the data collection, see: Cosier & Glazer (1986 ▶).

Experimental

Crystal data

C6H10N2O M = 126.16 Monoclinic, a = 8.374 (2) Å b = 7.2881 (16) Å c = 11.300 (3) Å β = 109.955 (5)° V = 648.3 (3) Å3 Z = 4 Mo Kα radiation μ = 0.09 mm−1 T = 100 K 0.52 × 0.16 × 0.09 mm

Data collection

Bruker APEXII DUO CCD area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2009 ▶) T min = 0.954, T max = 0.992 10018 measured reflections 2745 independent reflections 2325 reflections with I > 2σ(I) R int = 0.029

Refinement

R[F 2 > 2σ(F 2)] = 0.039 wR(F 2) = 0.123 S = 1.14 2745 reflections 122 parameters All H-atom parameters refined Δρmax = 0.52 e Å−3 Δρmin = −0.35 e Å−3 Data collection: APEX2 (Bruker, 2009 ▶); cell refinement: SAINT (Bruker, 2009 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXTL (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S160053681001696X/wn2385sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S160053681001696X/wn2385Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C6H10N2OF(000) = 272
Mr = 126.16Dx = 1.293 Mg m3
Monoclinic, P21/cMo Kα radiation, λ = 0.71073 Å
Hall symbol: -P 2ybcCell parameters from 3666 reflections
a = 8.374 (2) Åθ = 2.6–34.5°
b = 7.2881 (16) ŵ = 0.09 mm1
c = 11.300 (3) ÅT = 100 K
β = 109.955 (5)°Plate, colourless
V = 648.3 (3) Å30.52 × 0.16 × 0.09 mm
Z = 4
Bruker APEXII DUO CCD area-detector diffractometer2745 independent reflections
Radiation source: fine-focus sealed tube2325 reflections with I > 2σ(I)
graphiteRint = 0.029
φ and ω scansθmax = 34.6°, θmin = 3.4°
Absorption correction: multi-scan (SADABS; Bruker, 2009)h = −13→13
Tmin = 0.954, Tmax = 0.992k = −11→11
10018 measured reflectionsl = −18→17
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.039Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.123All H-atom parameters refined
S = 1.14w = 1/[σ2(Fo2) + (0.0715P)2 + 0.0472P] where P = (Fo2 + 2Fc2)/3
2745 reflections(Δ/σ)max < 0.001
122 parametersΔρmax = 0.52 e Å3
0 restraintsΔρmin = −0.35 e Å3
Experimental. The crystal was placed in the cold stream of an Oxford Cyrosystems Cobra open-flow nitrogen cryostat (Cosier & Glazer, 1986) operating at 100.0 (1) K.
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
O10.42822 (7)0.62337 (8)0.11992 (5)0.01463 (13)
N10.42529 (8)0.69441 (9)−0.08076 (6)0.01353 (13)
N20.35794 (9)0.82809 (9)−0.16813 (6)0.01431 (13)
C10.38533 (9)0.73007 (10)0.02374 (6)0.01110 (13)
C20.29351 (9)0.89787 (9)0.00188 (6)0.01142 (13)
C30.28136 (9)0.95309 (10)−0.11791 (7)0.01249 (14)
C40.19811 (10)1.11714 (10)−0.19250 (7)0.01638 (15)
C50.05452 (11)1.06785 (12)−0.31308 (8)0.02089 (17)
C60.22769 (10)0.99011 (11)0.09370 (7)0.01700 (15)
H4A0.1538 (18)1.1950 (18)−0.1386 (13)0.026 (3)*
H4B0.2822 (16)1.1904 (17)−0.2159 (11)0.019 (3)*
H5A−0.0064 (17)1.1779 (18)−0.3632 (13)0.025 (3)*
H5B−0.0336 (19)0.991 (2)−0.2946 (14)0.038 (4)*
H5C0.0961 (19)0.994 (2)−0.3704 (15)0.036 (4)*
H6A0.3195 (17)1.0187 (18)0.1773 (13)0.027 (3)*
H6B0.147 (2)0.9115 (19)0.1185 (14)0.033 (4)*
H6C0.163 (2)1.103 (2)0.0557 (16)0.044 (4)*
H1N10.4808 (19)0.5936 (19)−0.0921 (14)0.028 (3)*
H1N20.3762 (17)0.8332 (19)−0.2486 (13)0.028 (3)*
U11U22U33U12U13U23
O10.0221 (3)0.0147 (2)0.0089 (2)0.00498 (18)0.00754 (19)0.00296 (17)
N10.0211 (3)0.0125 (3)0.0092 (2)0.0048 (2)0.0080 (2)0.00233 (19)
N20.0221 (3)0.0130 (3)0.0098 (3)0.0033 (2)0.0080 (2)0.0027 (2)
C10.0144 (3)0.0120 (3)0.0078 (3)0.0006 (2)0.0050 (2)−0.0002 (2)
C20.0142 (3)0.0109 (3)0.0096 (3)0.0009 (2)0.0047 (2)−0.0003 (2)
C30.0159 (3)0.0106 (3)0.0110 (3)0.0000 (2)0.0047 (2)0.0000 (2)
C40.0213 (3)0.0118 (3)0.0143 (3)0.0012 (2)0.0039 (3)0.0027 (2)
C50.0212 (3)0.0193 (3)0.0178 (3)0.0024 (3)0.0010 (3)0.0032 (3)
C60.0208 (3)0.0187 (3)0.0132 (3)0.0048 (3)0.0079 (3)−0.0015 (3)
O1—C11.2839 (9)C4—C51.5209 (12)
N1—C11.3578 (9)C4—H4A0.993 (14)
N1—N21.3645 (9)C4—H4B0.989 (13)
N1—H1N10.902 (14)C5—H5A1.013 (13)
N2—C31.3459 (10)C5—H5B1.003 (15)
N2—H1N20.972 (14)C5—H5C0.992 (16)
C1—C21.4206 (10)C6—H6A1.015 (13)
C2—C31.3823 (10)C6—H6B0.994 (15)
C2—C61.4908 (10)C6—H6C1.000 (16)
C3—C41.4916 (11)
C1—N1—N2109.19 (6)C5—C4—H4A109.8 (8)
C1—N1—H1N1124.9 (9)C3—C4—H4B110.2 (7)
N2—N1—H1N1125.8 (9)C5—C4—H4B107.8 (7)
C3—N2—N1108.49 (6)H4A—C4—H4B107.7 (11)
C3—N2—H1N2128.1 (8)C4—C5—H5A114.0 (8)
N1—N2—H1N2123.1 (8)C4—C5—H5B111.0 (9)
O1—C1—N1122.64 (7)H5A—C5—H5B106.9 (12)
O1—C1—C2130.32 (6)C4—C5—H5C111.5 (9)
N1—C1—C2107.04 (6)H5A—C5—H5C106.6 (12)
C3—C2—C1105.99 (6)H5B—C5—H5C106.3 (12)
C3—C2—C6128.98 (7)C2—C6—H6A113.4 (8)
C1—C2—C6125.03 (6)C2—C6—H6B112.5 (9)
N2—C3—C2109.23 (6)H6A—C6—H6B103.1 (11)
N2—C3—C4120.16 (7)C2—C6—H6C110.4 (10)
C2—C3—C4130.59 (7)H6A—C6—H6C110.9 (12)
C3—C4—C5113.02 (7)H6B—C6—H6C106.1 (13)
C3—C4—H4A108.2 (8)
C1—N1—N2—C32.59 (8)N1—N2—C3—C4179.19 (6)
N2—N1—C1—O1177.88 (7)C1—C2—C3—N20.73 (8)
N2—N1—C1—C2−2.09 (8)C6—C2—C3—N2−179.69 (7)
O1—C1—C2—C3−179.13 (7)C1—C2—C3—C4179.34 (7)
N1—C1—C2—C30.84 (8)C6—C2—C3—C4−1.08 (13)
O1—C1—C2—C61.27 (12)N2—C3—C4—C560.72 (10)
N1—C1—C2—C6−178.76 (7)C2—C3—C4—C5−117.76 (9)
N1—N2—C3—C2−2.03 (8)
Cg1 is the centroid of the 1H-pyrazole ring (C1–C3/N1/N2).
D—H···AD—HH···AD···AD—H···A
N1—H1N1···O1i0.902 (15)1.829 (15)2.7267 (11)174.0 (16)
N2—H1N2···O1ii0.972 (14)1.715 (14)2.6777 (10)169.9 (13)
C5—H5A···Cg1iii1.013 (13)2.896 (15)3.6749 (14)134.2 (11)
Table 1

Hydrogen-bond geometry (Å, °)

Cg1 is the centroid of the 1H-pyrazole ring (C1–C3/N1/N2).

D—H⋯AD—HH⋯ADAD—H⋯A
N1—H1N1⋯O1i0.902 (15)1.829 (15)2.7267 (11)174.0 (16)
N2—H1N2⋯O1ii0.972 (14)1.715 (14)2.6777 (10)169.9 (13)
C5—H5ACg1iii1.013 (13)2.896 (15)3.6749 (14)134.2 (11)

Symmetry codes: (i) ; (ii) ; (iii) .

  12 in total

1.  Effect of anti-inflammatory and analgesic pyrazoles on arachidonic acid metabolism in isolated heart and gastric mucosa preparations.

Authors:  C Coersmeier; H R Wittenberg; U Aehringhaus; K W Dreyling; B M Peskar; K Brune; B A Peskar
Journal:  Agents Actions Suppl       Date:  1986

2.  Effects of a novel free radical scavenger, MCl-186, on ischemic brain damage in the rat distal middle cerebral artery occlusion model.

Authors:  H Kawai; H Nakai; M Suga; S Yuki; T Watanabe; K I Saito
Journal:  J Pharmacol Exp Ther       Date:  1997-05       Impact factor: 4.030

3.  Synthesis and preliminary evaluation of new 5-pyrazolinone derivatives as analgesic agents.

Authors:  A Gürsoy; S Demirayak; G Capan; K Erol; K Vural
Journal:  Eur J Med Chem       Date:  2000-03       Impact factor: 6.514

4.  Synthesis and antimicrobial activities of novel 1,5-diaryl pyrazoles.

Authors:  R Venkat Ragavan; V Vijayakumar; N Suchetha Kumari
Journal:  Eur J Med Chem       Date:  2009-12-28       Impact factor: 6.514

5.  Tert-butyl 3-oxo-2,3,4,5,6,7-hexa-hydro-1H-pyrazolo[4,3-c]pyridine-5-carboxyl-ate.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-12-16

Review 6.  Pyrazolone derivatives.

Authors:  R N Brogden
Journal:  Drugs       Date:  1986       Impact factor: 9.546

7.  Synthesis of some novel bioactive 4-oxy/thio substituted-1H-pyrazol-5(4H)-ones via efficient cross-Claisen condensation.

Authors:  R Venkat Ragavan; V Vijayakumar; N Suchetha Kumari
Journal:  Eur J Med Chem       Date:  2009-04-14       Impact factor: 6.514

8.  Myocardial protection of MCI-186 in rabbit ischemia-reperfusion.

Authors:  Tai-Wing Wu; Ling-Hua Zeng; Jun Wu; Kwok-Pui Fung
Journal:  Life Sci       Date:  2002-09-27       Impact factor: 5.037

9.  Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions.

Authors:  T Watanabe; S Yuki; M Egawa; H Nishi
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

10.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
View more
  11 in total

1.  5-Cyclo-hexyl-4-methyl-1H-pyrazol-3(2H)-one monohydrate.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-09

2.  5-Pentyl-4-phenyl-sulfonyl-1H-pyrazol-3-ol.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-05-29

3.  3-Ethyl-4-phen-oxy-1-(2,2,2-trifluoro-eth-yl)-1H-pyrazol-5-ol.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-07-07

4.  1,3-Dimethyl-4-phenyl-sulfanyl-1H-pyrazol-5-ol.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-02-16

5.  4-Methyl-5-phenyl-1H-pyrazol-3-ol.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-18

6.  3-Isobutyl-4-phenyl-sulfan-yl-1H-pyrazol-5-ol.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-22

7.  1-(4-Fluoro-phen-yl)-3-methyl-4-phenyl-sulfanyl-1H-pyrazol-5(4H)-one.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; M Venkatesh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-10-20

8.  5-Ethyl-2-(4-fluoro-phen-yl)-4-phen-oxy-1H-pyrazol-3(2H)-one.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; M Venkatesh
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-22

9.  4-{2-[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]thia-zol-4-yl}benzonitrile.

Authors:  Tara Shahani; Hoong-Kun Fun; R Venkat Ragavan; V Vijayakumar; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-08-11

10.  4-{[5-(4-Chloro-phen-yl)-1-(4-fluoro-phen-yl)-1H-pyrazol-3-yl]carbon-yl}-N-ethyl-piperazine-1-carboxamide.

Authors:  Tara Shahani; Hoong-Kun Fun; V Vijayakumar; R Venkat Ragavan; S Sarveswari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.